1. Home
  2. AEON

as 05-24-2024 4:00pm EST

$
-
.
-
-
+$
-
.
-
-
+
-
.
-
-
%

Health Care

Biotechnology: Pharmaceutical Preparations

Nasdaq

AEON Biopharma Inc is a clinical stage biopharmaceutical company focused on developing of its proprietary botulinum toxin complex ABP-450 (prabotulinumtoxinA) injection for debilitating medical conditions, with an initial focus on the neurosciences market.

Founded: N/A Country:
United States
United States
Employees: N/A City: IRVINE
Market Cap: 61.3M IPO Year: N/A
Target Price: $6.00 AVG Volume (30 days): 102.2K
Analyst Decision: Strong Buy Number of Analysts: 1
Dividend Yield: N/A Dividend Payout Frequency: N/A
EPS: -8.72 EPS Growth: N/A
52 Week Low/High: $1.38 - $17.17 Next Earning Date: 05-14-2024
Revenue: N/A Revenue Growth: N/A
Revenue Growth (this year): N/A Revenue Growth (next year): N/A

AEON Daily Stock ML Predictions

Share on Social Networks: